A Comparison of NETSPOT Imaging Versus F-FDG-PET in Head and Neck Cancer Patients
Phase of Trial: Phase II
Latest Information Update: 18 Feb 2019
At a glance
- Drugs Gallium 68-DOTATATE (Primary) ; Fludeoxyglucose F-18
- Indications Head and neck cancer; Squamous cell cancer
- Focus Diagnostic use; Proof of concept
- 01 Feb 2019 Planned primary completion date changed from 1 Jan 2019 to 30 Mar 2019.
- 01 Feb 2019 Status changed from not yet recruiting to recruiting.
- 31 Jul 2018 New trial record